ANZDATA Peritoneal Dialysis Report

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Focus on Dialysis and Kidney Transplant (Relates to.
End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Lily Mushahar Anita Bhajan Manocha Source: 20 th MDTR Report 2012, NRR.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Renal Medicine David Johnson Princess Alexandra Hospital Brisbane, Australia A Comparison of APD vs CAPD on Patient Outcomes A Comparison of APD vs CAPD.
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
ASSOCIATION OF SOCIO-ECONOMIC POSITION WITH TECHNIQUE FAILURE AND MORTALITY IN AUSTRALIAN NON-INDIGENOUS PERITONEAL DIALYSIS PATIENTS Dr Samuel Chan Nephrology.
Volume 59, Issue 2, Pages (February 2001)
First-year death rates by modality figure 8
West Midlands Renal Peer Review
Prevalence (pmp) of Renal Replacement Therapy
The ADEMEX Trial Adequacy of PD in Mexico Reference
December 31st point prevalent counts by modality figure 3.1
The CANUSA Trial Reference
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
CHAPTER 5 Paediatric Renal Replacement Therapy
CHAPTER 7 Nutritional Status on Dialysis
CHAPTER 3 Death and Survival on Dialysis
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
METHOD AND LOCATION OF DIALYSIS CHAPTER 4.
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
ANZDATA Registry Annual Report 2013
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial  Hao Yan, MD, Wei Fang, MD,
Volume 73, Issue 4, Pages (February 2008)
Volume 78, Issue 6, Pages (September 2010)
Cause Specific Death Rates for All Dialysis Patients
What really happens to people on long-term peritoneal dialysis?
Body size and outcomes on peritoneal dialysis in the United States
2013 Annual Report - 36th Edition
Volume 54, Issue 2, Pages (August 1998)
Peritoneal dialysis adequacy and risk of death
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function  S.L.S. Fan, T. Pile, S. Punzalan, M.J.
Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.
Adult peritoneal dialysis patients
American Journal of Kidney Diseases
Volume 59, Issue 2, Pages (February 2001)
Volume 65, Issue 1, Pages (January 2004)
Update from the Haemodialysis Working Group
Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary 
Dialysis outcomes in Australia & New Zealand
Stock and Flow of Haemodialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

ANZDATA Peritoneal Dialysis Report Dr John Collins Melbourne March 2000

Proportion (%) CAPD of all HD and PD Patients Australia and New Zealand

Stock and Flow of CAPD Patients Australia 1992 - 1999* Number of Patients (Data to 30 Sept) Extrapolated * * 1399 Patients 92 93 94 95 96 97 98 99

Stock and Flow of CAPD Patients New Zealand 1992 - 1999* Number of Patients (Data to 30 Sept) Extrapolated * * 599 Patients 92 93 94 95 96 97 98 99

Relationship of BMI to Weekly Dialysate Volume Australia 1995-1999  

Relationship of BMI to Weekly Dialysate Volume Australia 1995-1999  

Relationship of BMI to Weekly Dialysate Volume New Zealand 1995-1999  

Relationship of BMI to Weekly Dialysate Volume New Zealand 1995-1999  

Peritonitis Free Survival Related to Race April 1991 to March 1995 Australia Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs 55-64 yrs Aboriginal Maori/Pac Isl

Peritonitis Free Survival Related to Race April 1995 to March 1999 Australia Caucasoid 55-64 yrs 35-54 yrs 55-64 yrs 35-54 yrs Aboriginal Maori/Pac Isl

Peritonitis Free Survival Related to Race April 1991 to March 1995 New Zealand Caucasoid 55-64 yrs 35-54 yrs Maori/Pac Isl 35-54 yrs 55-64 yrs

Peritonitis Free Survival Related to Race April 1995 to March 1999 New Zealand Caucasoid 35-54 yrs 55-64 yrs Maori/Pac Isl 35-54 yrs 55-64 yrs

First CAPD Treatment to First Peritonitis Related to Age at Entry 1995-1998 % Survival Australia Age Group

First CAPD Treatment to First Peritonitis Related to Age at Entry 1995-1998 % Survival New Zealand Age Group

Technique Survival PD (Censor Death and Transplantation) Racial Origin 1990-1994 Australia Cauc vs Aboriginal p = 0.0326

Technique Survival PD (Censor Death and Transplantation) Racial Origin 1990-1994 New Zealand Cauc vs Pac Isl p = 0.0002 Maori vs Pac Isl p = 0.0254 Other vs Pac Isl p = 0.0206

Peritoneal Transport Status New Patients 1-Oct-98 to 30-Sep-99

PET D/P Creatinine at Four Hours New PD Patients from 1-Oct-98

Kt/V on Peritoneal Dialysis 30-Sep-99 Related to Residual GFR Australia and New Zealand %

Time on Peritoneal Dialysis 30-Sep-99 Related to Residual GFR Australia and New Zealand %

Total Creatinine Clearance on PD Related to Residual GFR 30-Sep-99 Australia and New Zealand %

Achieved Creatinine Clearance on PD Related to B.M.I. 30-Sep-99 Australia and New Zealand %

Peritoneal Dialysis Patient Survival Related to Initial B. M. I Peritoneal Dialysis Patient Survival Related to Initial B.M.I. 1991 to Sep-99 Australia and New Zealand B.M.I. B.M.I. <20 vs >27.5 p=0.0162 Censored at transplant only/death = failure

Creatinine Clearance on Peritoneal Dialysis Related to Weekly Dialysate 30-Sep-99 Australia and New Zealand n=351 n=243 n=700

Creatinine Clearance on Peritoneal Dialysis Related to Weekly Dialysate 30-Sep-99 % Kt/V  1.8 Australia and New Zealand n=353 n=243 n=701

Causes of Primary Technique Failure 1-Apr-94 to 31-Mar-99

Causes of Secondary Technique Failure 1-Apr-94 to 31-Mar-99

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.